You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

small intestine adenocarcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PillCamTM SB3 Capsule Endoscopy and Device-Assisted Enteroscopy

Not yet recruiting
  • Small Intestine Disease
  • +5 more
    • (no location specified)
    Jan 30, 2023

    Adenocarcinoma of Small Intestine, Appendix Carcinoma, Metastatic Trial in Guangzhou (Surufatinib)

    Recruiting
    • Adenocarcinoma of Small Intestine
    • +2 more
    • Guangzhou, Guangdong, China
      The Sixth Affiliated Hospital of Sun Yat-sen University
    Jul 22, 2022

    PillCam SB3 Videos and Raw Data Files for Future Developments

    Recruiting
    • Small Intestine Disease
    • +5 more
      • Birmingham, Alabama
      • +25 more
      Jan 30, 2023

      Systemic Availability, Intestinal Absorption, Metabolism Trial in Leuven (SCFA)

      Recruiting
      • Systemic Availability
      • +3 more
      • SCFA
      • Leuven, Belgium
        KU Leuven
      Oct 13, 2023

      Digital 3D Reconstruction Predicts Small Bowel Length

      Recruiting
      • Small Intestine Length Measurement
      • Small intestine length measurement method
      • Chongqing, China
        Daping hospital
      Jul 17, 2022

      Postoperative Complications Trial (Arrangement of small intestine order before close the abdomen)

      Not yet recruiting
      • Postoperative Complications
      • Arrangement of small intestine order before close the abdomen
      • (no location specified)
      Aug 5, 2022

      Tumor Size and Prognosis in Small Bowel adenocarcinoma-a

      Completed
      • Prognosis
      • no interventions
      • Dalian, Liaoning, China
        Dalian Third People's Hospital Affiliated to Dalian Medical Univ
      Oct 11, 2023

      Small Intestine Trial in Wageningen (plant-based mild ketogenic controlled diet, high-fat shake)

      Recruiting
      • Small Intestine
      • plant-based mild ketogenic controlled diet
      • high-fat shake
      • Wageningen, Gelderland, Netherlands
        Wageningen University
      Sep 28, 2023

      Invasiveness for Small-sized Lung Adenocarcinoma

      Recruiting
      • Lung Adenocarcinoma, Stage I
      • Invasiveness diagnosis
      • Wuhan, Hubei, China
        Union Hospital, Tongji Medical College, Huazhong University of S
      Apr 13, 2023

      Small Intestine and Blood Fingerprint Study in Parkinson's

      Not yet recruiting
      • Parkinson Disease
      • Fluid biopsy capsule
      • Levodopa-Carbidopa Immediate Release
      • Calgary, Alberta, Canada
        University of Calgary
      Aug 15, 2023

      Proof of Concept, Irritable Bowel Syndrome Trial in Calgary (device, procedure, diagnostic test)

      Completed
      • Proof of Concept
      • Irritable Bowel Syndrome
      • Ingestible capsule
      • +2 more
      • Calgary, Alberta, Canada
        Cumming School of Medicine, University of Calgary
      Aug 31, 2022

      Obesity, Morbid Trial in Minya (biliary limb as fixed length, biliary limb as a percentage from small intestine length)

      Completed
      • Obesity, Morbid
      • biliary limb as fixed length
      • biliary limb as a percentage from small intestine length
      • Minya, Egypt
        Faculty of medicine
      May 7, 2022

      Healthy Volunteers Trial in Grenoble (Innovative medical device for sampling small intestine content)

      Not yet recruiting
      • Healthy Volunteers
      • Innovative medical device for sampling small intestine content
      • Grenoble, France
        University Hospital Grenoble Alpes
      Jul 25, 2022

      Depth of Small Bowel Insertion at Push Enteroscopy by Using

      Active, not recruiting
      • Obscure Gastrointestinal Bleeding
      • +3 more
      • Push enteroscopy
      • Toronto, Ontario, Canada
        St. Michael's Hospital
      Feb 7, 2023

      Pancreatic Ductal Adenocarcinoma, Refractory NSCLC Trial in Washington (Daratumumab, KRAS vaccine, Nivolumab)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Refractory Non-Small Cell Lung Cancer
      • Washington, District of Columbia
        Georgetown Lombardi Comprehensive Cancer Center
      Sep 1, 2023

      Diet, Healthy, Microbial Colonization Trial in Bern (Test meal (high fat = Nutricia Calogen®, or high carbohydrate = Nutricia

      Recruiting
      • Diet, Healthy
      • Microbial Colonization
      • Test meal (high fat = Nutricia Calogen®, or high carbohydrate = Nutricia preOp®)
      • Bern, Switzerland
        Inselspital
      May 24, 2022

      Metabolic Syndrome, Obesity, Overweight Trial in Wageningen (food product)

      Recruiting
      • Metabolic Syndrome
      • +5 more
      • food product
      • Wageningen, Gelderland, Netherlands
        Wageningen University
      Dec 15, 2021

      Diet, Healthy Trial in Bern (Diet modification)

      Recruiting
      • Diet, Healthy
      • Diet modification
      • Bern, Switzerland
        Inselspital
      May 24, 2022

      Non-small Cell Lung Adenocarcinoma, Squamous Cell Carcinoma of Lung Trial in Guangzhou (SI-B001, Docetaxel)

      Not yet recruiting
      • Non-small Cell Lung Adenocarcinoma
      • Squamous Cell Carcinoma of Lung
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Jul 5, 2023

      HIV, Weight Gain Trial in Helsinki (gastroscopy)

      Not yet recruiting
      • HIV Infections
      • Weight Gain
      • gastroscopy
      • Helsinki, Uusimaa, Finland
        Infectious Disease Clinic, Helsinki University Hospital
      Apr 6, 2022

      Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)

      Not yet recruiting
      • Non-Small-Cell Lung Carcinoma
      • +2 more
      • Liquid biopsy
      • (no location specified)
      Jan 24, 2023

      Healthy Trial in Örebro (Probiotic)

      Completed
      • Healthy
      • Probiotic
      • Örebro, Sweden
        Örebro University
      Jul 13, 2022

      NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • Phase I - Mirdametinib - Level 1
      • +4 more
      • (no location specified)
      Jul 7, 2023

      ALK-positive NSCLC Trial in Dallas (Ceritinib, Stereotactic ablative body radiation)

      Terminated
      Has Results
      • ALK-positive Non-small Cell Lung Cancer
      • Dallas, Texas
        UT Southwestern Medical Center
      Jan 31, 2023

      Multiple Sclerosis Trial in Calgary (SIMBA Capsule)

      Not yet recruiting
      • Multiple Sclerosis
      • SIMBA Capsule
      • Calgary, Alberta, Canada
        University of Calgary
      Apr 25, 2023